Theralase Technologies Inc. V.TLT

Theralase MSAB

[Eoganacht]

Our Medical and Scientific Advisory Board now consists of just one member - Dr. Ashish Kamat of MD Anderson Cancer Center.

[Legit62]

Whats up with that Eoganacht??

[Eoganacht]

I'm guessing partly an economy measure and partly clearing the deck for new indications?

[enriquesuave]

I agree most probably both as an economy measure and paving room for specialists in other cancer indications.  NMIIBC indication is all set and just needs to be completed or reach AA.  IMHO. Not that I suspect anything else, but who knows ,it could be that they are clearing house for a BO?  That would explain certain things,  it not counting on it just yet.

[ScienceFirst]

Advisors on MSAB  cost a lot.  Don't think they advise for peanuts.   Having their credibility, ask yourself if you would do it for peanuts?

[DJDawg]

I wondered if they did that to save money. Keep the most highly influential person on board for now. From what I recall Dr Kamat is a big name in this area. On the posters too. It is not like they wouldn't have input from all the PI's and site PI's as far as medical advice.

[Eoganacht]

Yes, I'm also guessing it's an economy measure. The MSAB has had only 2 members for over a year - Drs. Kamat & Wilson - but before that there were 5 members. Hopefully, before too long we should see new members who can advise Theralase about NSCLC and GBM.

[ScienceFirst]

 TLT entering a new phase (transitioning from a R&D to commercialization path - there's a clear terminology for that in that industry), even Dr. Lilge and Dr. Jewett agreed that TLT's move was a normal process. Go reread their quotes.  They have not been fabricated and have not been posted without their consents. It's been 4 months since they officially outlined their

[ScienceFirst]

ChatGpt typo ... lolll but when material knees will happen but when material news will happen